When Dr Arora was diagnosed with non-Hodgkin’s lymphoma in 2022, she crossed overnight from a practising doctor to a patient. Her recovery with ImmunoACT’s indigenous CAR-T therapy now sits at the intersection of medicine and markets, drawing interest in whether an Indian company can sustainably manufacture, price, and scale one of the world’s most …



